Proliferating-cell nuclear antigen (PCNA) as an Independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67

被引:52
作者
Taftachi, R
Ayhan, A
Ekici, S [1 ]
Ergen, A
Ozen, H
机构
[1] Univ Hacettepe, Sch Med, Div Urooncol, Dept Urol, TR-06100 Ankara, Turkey
[2] Univ Hacettepe, Sch Med, Div Urooncol, Dept Pathol, TR-06100 Ankara, Turkey
关键词
PCNA; Ki-67; radical prostatectomy; prognosis;
D O I
10.1111/j.1464-410X.2005.05356.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE To investigate the prognostic value of prostatic tumour cell proliferation, as measured by Ki-67 and proliferating cell nuclear antigen (PCNA), and to compare these measures in men at low and high risk for progression of tumour. PATIENTS AND METHODS Two groups of patients with prostate cancer, i.e. 'metastatic' (M, 22) who had pT3b-4aN0M0 and pTanyN1M0, and 'nonmetastatic' (NM, 18), who had less than or equal to pT3aN0M0 disease, were selected from a well-examined and mapped group of 114 treated by radical prostatectomy. Patients in the NM group were selected by the criteria of having a Gleason score of less than or equal to7. To assess proliferation, 1000 cells were counted at x400 magnification by two observers and the percentage of tumour cells positively stained with Ki-67 and PCNA defined as the Ki-67 and PCNA labelling index (LI), respectively. The two LI were compared in the NM and M groups, and the correlation of the Lis with pathological stage, progression and prostate-specific antigen (PSA)-free survival evaluated. Prognostic values of the LI were analysed using multivariate analysis. RESULTS The mean (range) follow-up was 33 (4-78) months. The mean Lis were higher in the M than the NM group for both PCNA and Ki-67 (P= 0.02 and 0.019, respectively). Both Lis were markedly different between the groups when stratified by progression, with both significantly higher in men with progression in the NM group. Both Lis had a significant association with Gleason score, pathological stage, progression and PSA-free survival. In multivariate analysis the PCNA LI, surgical margin status and pathological stage were independent factors for progression. CONCLUSION Tumour cell proliferation as assessed by Ki-67 or PCNA correlate significantly with progression. The PCNA Ll was an independent predictor of progression, especially in patients with a low risk of progression according to predefined criteria.
引用
收藏
页码:650 / 654
页数:5
相关论文
共 33 条
[1]
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer [J].
Aaltomaa, S ;
Lipponen, P ;
Vesalainen, S ;
AlaOpas, M ;
Eskelinen, M ;
Syrjanen, K .
EUROPEAN UROLOGY, 1997, 32 (04) :410-415
[2]
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy [J].
Bettencourt, MC ;
Bauer, JJ ;
Sesterhenn, IA ;
Mostofi, FK ;
McLeod, DG ;
Moul, JW .
JOURNAL OF UROLOGY, 1996, 156 (03) :1064-1068
[3]
MONOCLONAL-ANTIBODY KI-67 - ITS USE IN HISTOPATHOLOGY [J].
BROWN, DC ;
GATTER, KC .
HISTOPATHOLOGY, 1990, 17 (06) :489-503
[4]
Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer [J].
Bubendorf, L ;
Tapia, C ;
Gasser, TC ;
Casella, R ;
Grunder, B ;
Moch, H ;
Mihatsch, MJ ;
Sauter, G .
HUMAN PATHOLOGY, 1998, 29 (09) :949-954
[5]
CELLULAR PROLIFERATION IN PROSTATIC ADENOCARCINOMA AS ASSESSED BY BROMODEOXYURIDINE UPTAKE AND KI-67 AND PCNA EXPRESSION [J].
CHER, ML ;
CHEW, K ;
ROSENAU, W ;
CARROLL, PR .
PROSTATE, 1995, 26 (02) :87-93
[6]
COOPER EH, 1992, CANCER-AM CANCER SOC, V70, P225, DOI 10.1002/1097-0142(19920701)70:1+<225::AID-CNCR2820701309>3.0.CO
[7]
2-V
[8]
Determination of prognosis in patients with prostate cancer treated with radical prostatectomy:: Prognostic value of CD44v6 score [J].
Ekici, S ;
Ayhan, A ;
Kendi, S ;
Özen, H .
JOURNAL OF UROLOGY, 2002, 167 (05) :2037-2041
[9]
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
[10]
2-Y